PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Squalene Monooxygenase 28 Target Disease Heart Disease 118,291 1 0.00 -0.98 0.04 0.56
Steroid 5-Alpha-Reductase 293 Target Disease Hyperprolactinemia 4,112 1 0.00 -1.00 0.00 0.60
Steroid 5-Alpha-Reductase 293 Target Disease Hepatitis 163,842 1 0.00 -1.00 0.00 0.51
Steroid 5-Alpha-Reductase 293 Target Disease Menopause 19,680 1 0.00 -1.00 0.00 0.56
Steroid 5-Alpha-Reductase 293 Target Disease Panic Disorder 7,455 1 0.00 -1.00 0.00 0.59
Steroid 5-Alpha-Reductase 293 Target Disease Lung Cancer 91,416 1 0.00 -1.00 0.00 0.53
Steroid 5-Alpha-Reductase 293 Target Drug Kaempferol 2,992 1 0.00 -1.00 0.00 0.61
Steroid 5-Alpha-Reductase 293 Target Target ETS1 539 1 0.00 -1.00 0.00 0.67
Steroid 5-Alpha-Reductase 293 Target Target Insulin-Like Growth Factor 1 Receptor 1,052 1 0.00 -1.00 0.00 0.65
Steroid 5-Alpha-Reductase 293 Target Target Activin A 2,048 1 0.00 -1.00 0.00 0.63
Steroid 5-Alpha-Reductase 293 Target Disease Shock 134,031 2 0.00 -1.00 0.01 0.53
Steroid 5-Alpha-Reductase 293 Target Target Phospholipase A2 13,400 2 0.00 -1.00 0.01 0.59
Steroid 5-Alpha-Reductase 293 Target Disease Gynecomastia 2,594 3 0.00 -0.99 0.01 0.65
Steroid 5-Alpha-Reductase 293 Target Disease Breast Cancer 173,695 3 0.00 -0.99 0.01 0.54
Steroid 5-Alpha-Reductase 293 Target Target 11-Beta-Hydroxylase 721 4 0.01 -0.99 0.01 0.71
Steroid 5-Alpha-Reductase 293 Target Disease Baldness 865 5 0.01 -0.99 0.02 0.71
Steroid 5-Alpha-Reductase 293 Target Disease Cholesterol 182,390 9 0.00 -0.98 0.03 0.56
Steroid 5-Alpha-Reductase 293 Target Target Steroid Delta-Isomerase 22 1 0.01 -0.98 0.05 0.73
Steroid 5-Alpha-Reductase 293 Target Disease Benign Prostatic Hyperplasia 10,026 33 0.02 -0.94 0.11 0.69
Steroid Delta-Isomerase 22 Target Target Activin A 2,048 1 0.00 -0.98 0.05 0.67
Sulfonylurea Receptor 2b 13 Target Disease Stroke 146,992 1 0.00 -0.96 0.08 0.57
Sulfonylurea Receptor 2b 13 Target Disease Inflammation 252,734 1 0.00 -0.96 0.08 0.56
Sulfonylurea Receptor 2b 13 Target Disease Liver Disease 49,817 1 0.00 -0.96 0.08 0.59
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Overactive Bladder 3,492 1 0.01 -0.94 0.11 0.67
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Infection 766,637 1 0.00 -0.94 0.11 0.54
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Schizophrenia 77,034 1 0.00 -0.94 0.11 0.59
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Cholesterol 182,390 1 0.00 -0.94 0.11 0.57
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Diabetic Retinopathy 14,494 1 0.00 -0.94 0.11 0.63
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Seizures 66,465 1 0.00 -0.94 0.11 0.59
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Epilepsy 71,172 3 0.00 -0.82 0.33 0.62
Tachykinin Receptor 1 13 Target Disease Inflammation 252,734 1 0.00 -0.96 0.08 0.56
Tachykinin Receptor 1 13 Target Disease Anxiety Disorder 8,985 1 0.00 -0.96 0.08 0.64
Tachykinin Receptor 1 13 Target Disease Dyslexia 3,832 1 0.00 -0.96 0.08 0.66
Tegument Protein Vp16 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
Tegument Protein Vp16 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
Tegument Protein Vp16 19 Target Disease Genital Herpes 2,660 2 0.01 -0.95 0.11 0.68
Tissue-Type Plasminogen Activator 5,020 Target Disease Dyskinesia 9,738 1 0.00 -1.00 0.00 0.52
Tissue-Type Plasminogen Activator 5,020 Target Disease Keratitis 10,599 1 0.00 -1.00 0.00 0.52
Tissue-Type Plasminogen Activator 5,020 Target Disease Neutropenia 25,934 1 0.00 -1.00 0.00 0.49
Tissue-Type Plasminogen Activator 5,020 Target Disease Ileus 9,091 1 0.00 -1.00 0.00 0.52
Tissue-Type Plasminogen Activator 5,020 Target Disease Scoliosis 14,102 1 0.00 -1.00 0.00 0.51
Tissue-Type Plasminogen Activator 5,020 Target Disease Myelodysplastic Syndrome 7,378 1 0.00 -1.00 0.00 0.53
Tissue-Type Plasminogen Activator 5,020 Target Disease Ankylosing Spondylitis 9,665 1 0.00 -1.00 0.00 0.52
Tissue-Type Plasminogen Activator 5,020 Target Disease Hypothyroidism 23,397 1 0.00 -1.00 0.00 0.50
Tissue-Type Plasminogen Activator 5,020 Target Disease Vertigo 10,084 1 0.00 -1.00 0.00 0.52
Tissue-Type Plasminogen Activator 5,020 Target Disease Malnutrition 27,452 1 0.00 -1.00 0.00 0.49
Tissue-Type Plasminogen Activator 5,020 Target Target Cox-2 21,583 1 0.00 -1.00 0.00 0.50
Tissue-Type Plasminogen Activator 5,020 Target Disease Inflammatory Bowel Diseases 4,684 1 0.00 -1.00 0.00 0.54
Tissue-Type Plasminogen Activator 5,020 Target Target BMP-2 3,889 1 0.00 -1.00 0.00 0.54
Tissue-Type Plasminogen Activator 5,020 Target Disease Familial Adenomatous Polyposis 3,742 1 0.00 -1.00 0.00 0.54
Tissue-Type Plasminogen Activator 5,020 Target Disease Skin Rash 3,684 1 0.00 -1.00 0.00 0.55
Tissue-Type Plasminogen Activator 5,020 Target Disease Chronic Alcoholism 3,068 1 0.00 -1.00 0.00 0.55
Tissue-Type Plasminogen Activator 5,020 Target Disease Epilepsy 71,172 2 0.00 -1.00 0.00 0.49
Tissue-Type Plasminogen Activator 5,020 Target Disease Allergic Rhinitis 12,280 2 0.00 -1.00 0.00 0.53
Tissue-Type Plasminogen Activator 5,020 Target Disease Attention Deficit Hyperactivity Disorder 14,687 2 0.00 -1.00 0.00 0.53
Tissue-Type Plasminogen Activator 5,020 Target Disease Migraine 24,200 2 0.00 -1.00 0.00 0.51
Tissue-Type Plasminogen Activator 5,020 Target Disease Sickle Cell 17,551 2 0.00 -1.00 0.00 0.52
Tissue-Type Plasminogen Activator 5,020 Target Disease Gastritis 17,713 2 0.00 -1.00 0.00 0.52
Tissue-Type Plasminogen Activator 5,020 Target Disease Asthma 109,610 2 0.00 -1.00 0.00 0.48
Tissue-Type Plasminogen Activator 5,020 Target Disease Sinusitis 12,330 2 0.00 -1.00 0.00 0.53
Tissue-Type Plasminogen Activator 5,020 Target Disease Urticaria 10,717 2 0.00 -1.00 0.00 0.54
Tissue-Type Plasminogen Activator 5,020 Target Drug Doxycycline 9,324 2 0.00 -1.00 0.00 0.54
Tissue-Type Plasminogen Activator 5,020 Target Target CD34 24,598 2 0.00 -1.00 0.00 0.51
Tissue-Type Plasminogen Activator 5,020 Target Target CER 2,421 1 0.00 -1.00 0.00 0.56
Tissue-Type Plasminogen Activator 5,020 Target Disease Testicular Cancer 4,459 2 0.00 -1.00 0.00 0.56
Tissue-Type Plasminogen Activator 5,020 Target Disease Bacterial Infections 14,248 3 0.00 -1.00 0.00 0.54
Tissue-Type Plasminogen Activator 5,020 Target Disease Mesothelioma 11,198 3 0.00 -1.00 0.00 0.55
Tissue-Type Plasminogen Activator 5,020 Target Target ERK2 3,287 2 0.00 -1.00 0.00 0.57
Tissue-Type Plasminogen Activator 5,020 Target Target Sphingomyelinase 3,060 2 0.00 -1.00 0.00 0.57
Tissue-Type Plasminogen Activator 5,020 Target Target Endoglin 1,333 1 0.00 -1.00 0.00 0.57
Tissue-Type Plasminogen Activator 5,020 Target Disease Angioedema 3,997 3 0.00 -1.00 0.00 0.58
Tissue-Type Plasminogen Activator 5,020 Target Disease Major Depressive Disorder 12,517 4 0.00 -1.00 0.00 0.55
Tissue-Type Plasminogen Activator 5,020 Target Disease Headache 50,687 4 0.00 -1.00 0.00 0.51
Tissue-Type Plasminogen Activator 5,020 Target Disease Diabetic Retinopathy 14,494 4 0.00 -1.00 0.00 0.55
Tissue-Type Plasminogen Activator 5,020 Target Target C7 7,027 4 0.00 -1.00 0.00 0.57
Tissue-Type Plasminogen Activator 5,020 Target Target Buserelin 1,249 1 0.00 -1.00 0.00 0.57
Tissue-Type Plasminogen Activator 5,020 Target Target Galectin-1 1,131 1 0.00 -1.00 0.00 0.57
Tissue-Type Plasminogen Activator 5,020 Target Disease Menopause 19,680 5 0.00 -1.00 0.00 0.54
Tissue-Type Plasminogen Activator 5,020 Target Disease Dyslipidemia 15,225 5 0.00 -1.00 0.00 0.55
Tissue-Type Plasminogen Activator 5,020 Target Disease Glioblastoma 17,933 5 0.00 -1.00 0.00 0.55
Tissue-Type Plasminogen Activator 5,020 Target Target AGP 2,006 2 0.00 -1.00 0.00 0.58
Tissue-Type Plasminogen Activator 5,020 Target Target aFGF 899 1 0.00 -1.00 0.00 0.58
Tissue-Type Plasminogen Activator 5,020 Target Disease Noninsulin Dependent Diabetes Mellitus 839 1 0.00 -1.00 0.00 0.58
Tissue-Type Plasminogen Activator 5,020 Target Disease Brain Tumors 16,749 6 0.00 -1.00 0.00 0.56
Tissue-Type Plasminogen Activator 5,020 Target Disease Proteinuria 28,803 6 0.00 -1.00 0.00 0.54
Tissue-Type Plasminogen Activator 5,020 Target Disease Nephrotic Syndrome 14,681 6 0.00 -1.00 0.00 0.56
Tissue-Type Plasminogen Activator 5,020 Target Disease Seizures 66,465 6 0.00 -1.00 0.00 0.52
Tissue-Type Plasminogen Activator 5,020 Target Disease Contraception 21,402 6 0.00 -1.00 0.00 0.55
Tissue-Type Plasminogen Activator 5,020 Target Disease Infertility 35,448 6 0.00 -1.00 0.00 0.53
Tissue-Type Plasminogen Activator 5,020 Target Disease Hyperlipoproteinemia 2,954 4 0.00 -1.00 0.00 0.59
Tissue-Type Plasminogen Activator 5,020 Target Disease Hepatitis 163,842 7 0.00 -1.00 0.00 0.50
Tissue-Type Plasminogen Activator 5,020 Target Disease Psoriasis 26,882 7 0.00 -1.00 0.00 0.55
Tissue-Type Plasminogen Activator 5,020 Target Target Dihydrofolate Reductase 5,563 7 0.00 -1.00 0.00 0.60
Tissue-Type Plasminogen Activator 5,020 Target Disease Dementia 66,782 9 0.00 -1.00 0.00 0.53
Tissue-Type Plasminogen Activator 5,020 Target Disease Lung Cancer 91,416 9 0.00 -1.00 0.00 0.52
Tissue-Type Plasminogen Activator 5,020 Target Disease Liver Disease 49,817 9 0.00 -1.00 0.00 0.53
Tissue-Type Plasminogen Activator 5,020 Target Target APOE 12,771 9 0.00 -1.00 0.00 0.58
Tissue-Type Plasminogen Activator 5,020 Target Target BDNF 11,163 12 0.00 -1.00 0.00 0.59
Tissue-Type Plasminogen Activator 5,020 Target Target Cytokeratin 18 1,108 3 0.00 -1.00 0.00 0.61
Tissue-Type Plasminogen Activator 5,020 Target Target Collagenase 3 367 1 0.00 -1.00 0.00 0.59